Your browser doesn't support javascript.
loading
Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns.
Gougis, Paul; Grandal, Beatriz; Jochum, Floriane; Bihan, Kevin; Coussy, Florence; Barraud, Solenn; Asselain, Bernard; Dumas, Elise; Sebbag, Clara; Hotton, Judicael; Spaggiari, Emmanuel; Pierga, Jean-Yves; Savarino, Raphaëlle; Laas, Enora; Spano, Jean-Philippe; Reyal, Fabien; Hamy, Anne-Sophie.
Afiliação
  • Gougis P; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut National de la Santé et de la Recherche Médicale, U932 Immunity and Cancer, Institut Curie, Université Paris Cité, Paris, France.
  • Grandal B; Department of Medical Oncology, Pitié-Salpêtrière Hospital, Paris, France, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Jochum F; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Assistance Publique-Hôpitaux de Paris, Clinical Investigation Center (CIC-1901), Department of Pharmacology, Pitié-Salpêtrière Hospital, Paris, France.
  • Bihan K; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut National de la Santé et de la Recherche Médicale, U932 Immunity and Cancer, Institut Curie, Université Paris Cité, Paris, France.
  • Coussy F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut National de la Santé et de la Recherche Médicale, U932 Immunity and Cancer, Institut Curie, Université Paris Cité, Paris, France.
  • Barraud S; Department of Gynecology, Strasbourg University Hospital, Strasbourg, France.
  • Asselain B; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Assistance Publique-Hôpitaux de Paris, Clinical Investigation Center (CIC-1901), Department of Pharmacology, Pitié-Salpêtrière Hospital, Paris, France.
  • Dumas E; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut National de la Santé et de la Recherche Médicale, U932 Immunity and Cancer, Institut Curie, Université Paris Cité, Paris, France.
  • Sebbag C; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France.
  • Hotton J; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut National de la Santé et de la Recherche Médicale, U932 Immunity and Cancer, Institut Curie, Université Paris Cité, Paris, France.
  • Spaggiari E; Department of Statistics, Association de Recherche sur les Cancers dont Gynécologiques-Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du sein (ARCAGY-GINECO), Paris, France.
  • Pierga JY; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut National de la Santé et de la Recherche Médicale, U932 Immunity and Cancer, Institut Curie, Université Paris Cité, Paris, France.
  • Savarino R; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut National de la Santé et de la Recherche Médicale, U932 Immunity and Cancer, Institut Curie, Université Paris Cité, Paris, France.
  • Laas E; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France.
  • Spano JP; Department of Surgical Oncology, Institut Godinot, Reims, France.
  • Reyal F; Department of Obstetrics and Maternal-Fetal Medicine, Assistance Publique-Hôpitaux de Paris, Necker Enfants-Malades Hospital, Paris, France.
  • Hamy AS; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France.
JAMA Netw Open ; 6(10): e2339934, 2023 10 02.
Article em En | MEDLINE | ID: mdl-37883083

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Limite: Adult / Female / Humans / Newborn / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Limite: Adult / Female / Humans / Newborn / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article